Literature DB >> 18405318

What should research participants understand to understand they are participants in research?

David Wendler1, Christine Grady.   

Abstract

To give valid informed consent to participate in clinical research, potential participants should understand the risks, potential benefits, procedures, and alternatives. Potential participants also should understand that they are being invited to participate in research. Yet it is unclear what potential participants need to understand to satisfy this particular requirement. As a result, it is unclear what additional information investigators should disclose about the research; and it is also unclear when failures of understanding in this respect undermine the validity of potential participants' informed consent. An analysis of individuals' interests suggests that potential participants need to understand three additional facts to understand that they are being invited to participate in research: 1) research contribution: those who enroll in the study will be contributing to a project designed to gather generalizable knowledge to benefit others in the future; 2) research relationship: the investigators will rely on participants' efforts to gather the generalizable knowledge to benefit others; and 3) research impact: the extent to which participating in the study will alter what participants do and what happens to them.

Entities:  

Mesh:

Year:  2008        PMID: 18405318     DOI: 10.1111/j.1467-8519.2008.00632.x

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  23 in total

Review 1.  Informed consent in genomics and genetic research.

Authors:  Amy L McGuire; Laura M Beskow
Journal:  Annu Rev Genomics Hum Genet       Date:  2010       Impact factor: 8.929

Review 2.  "Targeted" consent for pragmatic clinical trials.

Authors:  David Wendler
Journal:  J Gen Intern Med       Date:  2015-01-14       Impact factor: 5.128

Review 3.  Lessons learned from the world's first successful penis allotransplantation.

Authors:  Andre van der Merwe; Amir Zarrabi; Alexander Zühlke; Nicola Barsdorf; Rafique Moosa
Journal:  J Mater Sci Mater Med       Date:  2017-01-10       Impact factor: 3.896

4.  Minority Veterans Are More Willing to Participate in Complex Studies Compared to Non-minorities.

Authors:  Leonardo Tamariz; Irene Kirolos; Fiorella Pendola; Erin N Marcus; Olveen Carrasquillo; Jimmy Rivadeneira; Ana Palacio
Journal:  J Bioeth Inq       Date:  2017-12-19       Impact factor: 1.352

5.  Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.

Authors:  Lauren M Hamel; Louis A Penner; Terrance L Albrecht; Elisabeth Heath; Clement K Gwede; Susan Eggly
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

6.  Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Authors:  Rebecca D Pentz; Margaret White; R Donald Harvey; Zachary Luke Farmer; Yuan Liu; Colleen Lewis; Olga Dashevskaya; Taofeek Owonikoko; Fadlo R Khuri
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

7.  Randomization to standard and concise informed consent forms: development of evidence-based consent practices.

Authors:  Mary E Enama; Zonghui Hu; Ingelise Gordon; Pamela Costner; Julie E Ledgerwood; Christine Grady
Journal:  Contemp Clin Trials       Date:  2012-04-20       Impact factor: 2.226

8.  Ancillary care in South African HIV vaccine trials: addressing needs, drafting protocols, and engaging community.

Authors:  Catherine M Slack
Journal:  J Empir Res Hum Res Ethics       Date:  2014-02       Impact factor: 1.742

9.  Cancer clinical trial participants' assessment of risk and benefit.

Authors:  Connie M Ulrich; Sarah J Ratcliffe; Gwenyth R Wallen; Qiuping Pearl Zhou; Kathleen Knafl; Christine Grady
Journal:  AJOB Empir Bioeth       Date:  2015-05-01

10.  Participants' recall and understanding of genomic research and large-scale data sharing.

Authors:  Jill Oliver Robinson; Melody J Slashinski; Tao Wang; Susan G Hilsenbeck; Amy L McGuire
Journal:  J Empir Res Hum Res Ethics       Date:  2013-10       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.